• Benign Prostatic Hyperplasia
  • Hormone Therapy
  • Genomic Testing
  • Next-Generation Imaging
  • UTUC
  • OAB and Incontinence
  • Genitourinary Cancers
  • Kidney Cancer
  • Men's Health
  • Pediatrics
  • Female Urology
  • Sexual Dysfunction
  • Kidney Stones
  • Urologic Surgery
  • Bladder Cancer
  • Benign Conditions
  • Prostate Cancer

Dr. Loeb named to Urology Times Editorial Council

Article

Urology Times is pleased to announce the appointment of Stacy Loeb, MD, MSc, to its Editorial Council, representing the areas of men’s health and prostate cancer.

Dr. LoebUrology Times is pleased to announce the appointment of Stacy Loeb, MD, MSc, to its Editorial Council, representing the areas of men’s health and prostate cancer.

Dr. Loeb is assistant professor of urology and population health at New York University School of Medicine, New York. An international leader in the field of prostate cancer, Dr. Loeb is the author of more than 200 published peer-reviewed articles and eight book chapters. She has a K07 grant from the National Cancer Institute to study active surveillance for prostate cancer.

She hosts the “Men’s Health Show” on Sirius XM 81 satellite radio and is active on Twitter using the handle @LoebStacy.

Dr. Loeb received her medical degree from Northwestern Feinberg School of Medicine, Chicago and completed her residency at Johns Hopkins University, Baltimore.

More from Urology Times:

Twitter’s benefits extend beyond ‘social’ aspects

Study appears to refute obesity paradox in kidney cancer

CNS may be path to future voiding dysfunction therapies

To get weekly news from the leading news source for urologists, subscribe to the Urology Times eNews.

Related Videos
Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com
Gamal M. Ghoniem, MD, FACS, ABU/FPMRS, gives an answer during a video interview
Edward M. Schaeffer, MD, PhD, answers a question during a Zoom video interview
Zhina Sadeghi, MD, answers a question during a video interview
A panel of 4 experts on prostate cancer
A panel of 4 experts on prostate cancer
A panel of 4 experts on prostate cancer
A panel of 4 experts on prostate cancer
© 2024 MJH Life Sciences

All rights reserved.